Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium-Reference-Cited by-同舟云学术

Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium

Published:2018-05-31 Issue:5 Volume:104 Page:803-817
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Yee Sook Wah¹,Brackman Deanna J.¹,Ennis Elizabeth A.¹,Sugiyama Yuichi²,Kamdem Landry K.³,Blanchard Rebecca⁴,Galetin Aleksandra⁵,Zhang Lei⁶,Giacomini Kathleen M.¹⁷

Affiliation:

1. Department of Bioengineering and Therapeutic Sciences; Schools of Pharmacy and Medicine, University of California; San Francisco, San Francisco California USA

2. Sugiyama Laboratory, RIKEN Innovation Center; Research Cluster for Innovation; RIKEN Yokohama Japan

3. Department of Pharmaceutical Sciences; Harding University College of Pharmacy; Searcy Arkansas USA

4. CRISPR Therapeutics; Cambridge Massachusetts USA

5. Centre for Applied Pharmacokinetic Research; School of Health Sciences, University of Manchester; UK

6. Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring Maryland USA

7. Institute of Human Genetics; University of California, San Francisco; San Francisco California USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1098/fullpdf

Reference108 articles.

1. Membrane transporters in drug development;International Transporter, C.;Nat. Rev. Drug Discov,2010

2. International Transporter Consortium commentary on clinically important transporter polymorphisms;Giacomini;Clin. Pharmacol. Ther.,2013